Cardiorenal effects of atrial natriuretic factor administration in congestive heart failure: Natriuresis and diuresis without hemodynamic alterations
Open Access
- 1 April 1989
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 297 (4) , 203-208
- https://doi.org/10.1097/00000441-198904000-00001
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Circulating atrial natriuretic polypeptide in essential hypertensionAmerican Heart Journal, 1987
- Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.Journal of Clinical Investigation, 1986
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart FailureNew England Journal of Medicine, 1986
- Atriopeptin: A Cardiac Hormone Intimately Involved in Fluid, Electrolyte, and Blood-Pressure HomeostasisNew England Journal of Medicine, 1986
- Atriopeptin III. A potent natriuretic, diuretic, and hypotensive agent in rats with chronic renal failure.Journal of Clinical Investigation, 1985
- ATRIAL NATRIURETIC PEPTIDE IN PLASMA OF VOLUME-OVERLOADED CHILDREN WITH CHRONIC RENAL FAILUREThe Lancet, 1985
- α-Human atrial natriuretic polypeptide is released from the heart and circulates in the bodyBiochemical and Biophysical Research Communications, 1985
- Atrial natriuretic factor—a circulating hormone stimulated by volume loadingNature, 1985
- The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclaseFEBS Letters, 1985
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981